We are thrilled to announce the opening of our state-of-the-art AI Research Center in Bern, Switzerland. This cutting-edge facility is dedicated to advancing the field of drug development through virtual design and compound screening. By leveraging the power of artificial intelligence, our expert team aims to accelerate the discovery of new, life-saving medications.
Our innovative approach integrates AI algorithms with advanced scientific research to identify promising drug candidates more efficiently than traditional methods. This not only shortens the development timeline but also reduces costs and enhances the precision of drug targeting.